[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Hepatitis B Vaccine (Recombinant) Market - Global Outlook and Forecast 2021-2027

April 2021 | 93 pages | ID: HA4932C3197BEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Hepatitis B Vaccine (Recombinant) in global, including the following market information:

Global Hepatitis B Vaccine (Recombinant) Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Hepatitis B Vaccine (Recombinant) Market Sales, 2016-2021, 2022-2027, (K Units)

Global top five Hepatitis B Vaccine (Recombinant) companies in 2020 (%)

The global Hepatitis B Vaccine (Recombinant) market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis B Vaccine (Recombinant) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hepatitis B Vaccine (Recombinant) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Hepatitis B Vaccine (Recombinant) Market Segment Percentages, By Type, 2020 (%)
  • 10mcg/0.5ml
  • 10mcg/ml
Global Hepatitis B Vaccine (Recombinant) Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Hepatitis B Vaccine (Recombinant) Market Segment Percentages, By Application, 2020 (%)
  • Newborn
  • Adult
Global Hepatitis B Vaccine (Recombinant) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Hepatitis B Vaccine (Recombinant) Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hepatitis B Vaccine (Recombinant) revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Hepatitis B Vaccine (Recombinant) revenues share in global market, 2020 (%)

Key companies Hepatitis B Vaccine (Recombinant) sales in global market, 2016-2021 (Estimated), (K Units)

Key companies Hepatitis B Vaccine (Recombinant) sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • GSK
  • Merck
  • Sanofi Pasteur
  • Dynavax Technologies
  • LG Life Sciences
  • KM Biologics
  • Shenzhen Kangtai Biological Products
  • Serum Institute
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hepatitis B Vaccine (Recombinant) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hepatitis B Vaccine (Recombinant) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEPATITIS B VACCINE (RECOMBINANT) OVERALL MARKET SIZE

2.1 Global Hepatitis B Vaccine (Recombinant) Market Size: 2021 VS 2027
2.2 Global Hepatitis B Vaccine (Recombinant) Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Hepatitis B Vaccine (Recombinant) Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Hepatitis B Vaccine (Recombinant) Players in Global Market
3.2 Top Global Hepatitis B Vaccine (Recombinant) Companies Ranked by Revenue
3.3 Global Hepatitis B Vaccine (Recombinant) Revenue by Companies
3.4 Global Hepatitis B Vaccine (Recombinant) Sales by Companies
3.5 Global Hepatitis B Vaccine (Recombinant) Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Hepatitis B Vaccine (Recombinant) Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Hepatitis B Vaccine (Recombinant) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis B Vaccine (Recombinant) Players in Global Market
  3.8.1 List of Global Tier 1 Hepatitis B Vaccine (Recombinant) Companies
  3.8.2 List of Global Tier 2 and Tier 3 Hepatitis B Vaccine (Recombinant) Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Hepatitis B Vaccine (Recombinant) Market Size Markets, 2021 & 2027
  4.1.2 10mcg/0.5ml
  4.1.3 10mcg/ml
4.2 By Type - Global Hepatitis B Vaccine (Recombinant) Revenue & Forecasts
  4.2.1 By Type - Global Hepatitis B Vaccine (Recombinant) Revenue, 2016-2021
  4.2.2 By Type - Global Hepatitis B Vaccine (Recombinant) Revenue, 2022-2027
  4.2.3 By Type - Global Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2016-2027
4.3 By Type - Global Hepatitis B Vaccine (Recombinant) Sales & Forecasts
  4.3.1 By Type - Global Hepatitis B Vaccine (Recombinant) Sales, 2016-2021
  4.3.2 By Type - Global Hepatitis B Vaccine (Recombinant) Sales, 2022-2027
  4.3.3 By Type - Global Hepatitis B Vaccine (Recombinant) Sales Market Share, 2016-2027
4.4 By Type - Global Hepatitis B Vaccine (Recombinant) Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hepatitis B Vaccine (Recombinant) Market Size, 2021 & 2027
  5.1.2 Newborn
  5.1.3 Adult
5.2 By Application - Global Hepatitis B Vaccine (Recombinant) Revenue & Forecasts
  5.2.1 By Application - Global Hepatitis B Vaccine (Recombinant) Revenue, 2016-2021
  5.2.2 By Application - Global Hepatitis B Vaccine (Recombinant) Revenue, 2022-2027
  5.2.3 By Application - Global Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2016-2027
5.3 By Application - Global Hepatitis B Vaccine (Recombinant) Sales & Forecasts
  5.3.1 By Application - Global Hepatitis B Vaccine (Recombinant) Sales, 2016-2021
  5.3.2 By Application - Global Hepatitis B Vaccine (Recombinant) Sales, 2022-2027
  5.3.3 By Application - Global Hepatitis B Vaccine (Recombinant) Sales Market Share, 2016-2027
5.4 By Application - Global Hepatitis B Vaccine (Recombinant) Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Hepatitis B Vaccine (Recombinant) Market Size, 2021 & 2027
6.2 By Region - Global Hepatitis B Vaccine (Recombinant) Revenue & Forecasts
  6.2.1 By Region - Global Hepatitis B Vaccine (Recombinant) Revenue, 2016-2021
  6.2.2 By Region - Global Hepatitis B Vaccine (Recombinant) Revenue, 2022-2027
  6.2.3 By Region - Global Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2016-2027
6.3 By Region - Global Hepatitis B Vaccine (Recombinant) Sales & Forecasts
  6.3.1 By Region - Global Hepatitis B Vaccine (Recombinant) Sales, 2016-2021
  6.3.2 By Region - Global Hepatitis B Vaccine (Recombinant) Sales, 2022-2027
  6.3.3 By Region - Global Hepatitis B Vaccine (Recombinant) Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Hepatitis B Vaccine (Recombinant) Revenue, 2016-2027
  6.4.2 By Country - North America Hepatitis B Vaccine (Recombinant) Sales, 2016-2027
  6.4.3 US Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.4.4 Canada Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.4.5 Mexico Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Hepatitis B Vaccine (Recombinant) Revenue, 2016-2027
  6.5.2 By Country - Europe Hepatitis B Vaccine (Recombinant) Sales, 2016-2027
  6.5.3 Germany Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.5.4 France Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.5.5 U.K. Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.5.6 Italy Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.5.7 Russia Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.5.8 Nordic Countries Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.5.9 Benelux Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Hepatitis B Vaccine (Recombinant) Revenue, 2016-2027
  6.6.2 By Region - Asia Hepatitis B Vaccine (Recombinant) Sales, 2016-2027
  6.6.3 China Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.6.4 Japan Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.6.5 South Korea Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.6.6 Southeast Asia Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.6.7 India Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Hepatitis B Vaccine (Recombinant) Revenue, 2016-2027
  6.7.2 By Country - South America Hepatitis B Vaccine (Recombinant) Sales, 2016-2027
  6.7.3 Brazil Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.7.4 Argentina Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales, 2016-2027
  6.8.3 Turkey Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.8.4 Israel Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.8.5 Saudi Arabia Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027
  6.8.6 UAE Hepatitis B Vaccine (Recombinant) Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 GSK
  7.1.1 GSK Corporate Summary
  7.1.2 GSK Business Overview
  7.1.3 GSK Hepatitis B Vaccine (Recombinant) Major Product Offerings
  7.1.4 GSK Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2016-2021)
  7.1.5 GSK Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Hepatitis B Vaccine (Recombinant) Major Product Offerings
  7.2.4 Merck Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2016-2021)
  7.2.5 Merck Key News
7.3 Sanofi Pasteur
  7.3.1 Sanofi Pasteur Corporate Summary
  7.3.2 Sanofi Pasteur Business Overview
  7.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Major Product Offerings
  7.3.4 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2016-2021)
  7.3.5 Sanofi Pasteur Key News
7.4 Dynavax Technologies
  7.4.1 Dynavax Technologies Corporate Summary
  7.4.2 Dynavax Technologies Business Overview
  7.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Major Product Offerings
  7.4.4 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2016-2021)
  7.4.5 Dynavax Technologies Key News
7.5 LG Life Sciences
  7.5.1 LG Life Sciences Corporate Summary
  7.5.2 LG Life Sciences Business Overview
  7.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Major Product Offerings
  7.5.4 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2016-2021)
  7.5.5 LG Life Sciences Key News
7.6 KM Biologics
  7.6.1 KM Biologics Corporate Summary
  7.6.2 KM Biologics Business Overview
  7.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Major Product Offerings
  7.6.4 KM Biologics Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2016-2021)
  7.6.5 KM Biologics Key News
7.7 Shenzhen Kangtai Biological Products
  7.7.1 Shenzhen Kangtai Biological Products Corporate Summary
  7.7.2 Shenzhen Kangtai Biological Products Business Overview
  7.7.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Major Product Offerings
  7.4.4 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2016-2021)
  7.7.5 Shenzhen Kangtai Biological Products Key News
7.8 Serum Institute
  7.8.1 Serum Institute Corporate Summary
  7.8.2 Serum Institute Business Overview
  7.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Major Product Offerings
  7.8.4 Serum Institute Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2016-2021)
  7.8.5 Serum Institute Key News

8 GLOBAL HEPATITIS B VACCINE (RECOMBINANT) PRODUCTION CAPACITY, ANALYSIS

8.1 Global Hepatitis B Vaccine (Recombinant) Production Capacity, 2016-2027
8.2 Hepatitis B Vaccine (Recombinant) Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis B Vaccine (Recombinant) Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 HEPATITIS B VACCINE (RECOMBINANT) SUPPLY CHAIN ANALYSIS

10.1 Hepatitis B Vaccine (Recombinant) Industry Value Chain
10.2 Hepatitis B Vaccine (Recombinant) Upstream Market
10.3 Hepatitis B Vaccine (Recombinant) Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Hepatitis B Vaccine (Recombinant) Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Hepatitis B Vaccine (Recombinant) in Global Market
Table 2. Top Hepatitis B Vaccine (Recombinant) Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Hepatitis B Vaccine (Recombinant) Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Companies, 2016-2021
Table 5. Global Hepatitis B Vaccine (Recombinant) Sales by Companies, (K Units), 2016-2021
Table 6. Global Hepatitis B Vaccine (Recombinant) Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Hepatitis B Vaccine (Recombinant) Price (2016-2021) & (US$/Unit)
Table 8. Global Manufacturers Hepatitis B Vaccine (Recombinant) Product Type
Table 9. List of Global Tier 1 Hepatitis B Vaccine (Recombinant) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Vaccine (Recombinant) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Hepatitis B Vaccine (Recombinant) Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Hepatitis B Vaccine (Recombinant) Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Hepatitis B Vaccine (Recombinant) Sales (K Units), 2016-2021
Table 15. By Type - Global Hepatitis B Vaccine (Recombinant) Sales (K Units), 2022-2027
Table 16. By Application – Global Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Hepatitis B Vaccine (Recombinant) Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Hepatitis B Vaccine (Recombinant) Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Hepatitis B Vaccine (Recombinant) Sales (K Units), 2016-2021
Table 20. By Application - Global Hepatitis B Vaccine (Recombinant) Sales (K Units), 2022-2027
Table 21. By Region – Global Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Hepatitis B Vaccine (Recombinant) Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Hepatitis B Vaccine (Recombinant) Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Hepatitis B Vaccine (Recombinant) Sales (K Units), 2016-2021
Table 25. By Region - Global Hepatitis B Vaccine (Recombinant) Sales (K Units), 2022-2027
Table 26. By Country - North America Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2016-2021
Table 29. By Country - North America Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2022-2027
Table 30. By Country - Europe Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2016-2021
Table 33. By Country - Europe Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2022-2027
Table 34. By Region - Asia Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2016-2021
Table 37. By Region - Asia Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2022-2027
Table 38. By Country - South America Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2016-2021
Table 41. By Country - South America Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2022-2027
Table 46. GSK Corporate Summary
Table 47. GSK Hepatitis B Vaccine (Recombinant) Product Offerings
Table 48. GSK Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 49. Merck Corporate Summary
Table 50. Merck Hepatitis B Vaccine (Recombinant) Product Offerings
Table 51. Merck Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 52. Sanofi Pasteur Corporate Summary
Table 53. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Offerings
Table 54. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 55. Dynavax Technologies Corporate Summary
Table 56. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Offerings
Table 57. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 58. LG Life Sciences Corporate Summary
Table 59. LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Offerings
Table 60. LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 61. KM Biologics Corporate Summary
Table 62. KM Biologics Hepatitis B Vaccine (Recombinant) Product Offerings
Table 63. KM Biologics Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 64. Shenzhen Kangtai Biological Products Corporate Summary
Table 65. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Offerings
Table 66. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 67. Serum Institute Corporate Summary
Table 68. Serum Institute Hepatitis B Vaccine (Recombinant) Product Offerings
Table 69. Serum Institute Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 70. Hepatitis B Vaccine (Recombinant) Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 71. Global Hepatitis B Vaccine (Recombinant) Capacity Market Share of Key Manufacturers, 2019-2021
Table 72. Global Hepatitis B Vaccine (Recombinant) Production by Region, 2016-2021 (K Units)
Table 73. Global Hepatitis B Vaccine (Recombinant) Production by Region, 2022-2027 (K Units)
Table 74. Hepatitis B Vaccine (Recombinant) Market Opportunities & Trends in Global Market
Table 75. Hepatitis B Vaccine (Recombinant) Market Drivers in Global Market
Table 76. Hepatitis B Vaccine (Recombinant) Market Restraints in Global Market
Table 77. Hepatitis B Vaccine (Recombinant) Raw Materials
Table 78. Hepatitis B Vaccine (Recombinant) Raw Materials Suppliers in Global Market
Table 79. Typical Hepatitis B Vaccine (Recombinant) Downstream
Table 80. Hepatitis B Vaccine (Recombinant) Downstream Clients in Global Market
Table 81. Hepatitis B Vaccine (Recombinant) Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Hepatitis B Vaccine (Recombinant) Segment by Type
Figure 2. Hepatitis B Vaccine (Recombinant) Segment by Application
Figure 3. Global Hepatitis B Vaccine (Recombinant) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Vaccine (Recombinant) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Hepatitis B Vaccine (Recombinant) Revenue, 2016-2027 (US$, Mn)
Figure 7. Hepatitis B Vaccine (Recombinant) Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis B Vaccine (Recombinant) Revenue in 2020
Figure 9. By Type - Global Hepatitis B Vaccine (Recombinant) Sales Market Share, 2016-2027
Figure 10. By Type - Global Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2016-2027
Figure 11. By Type - Global Hepatitis B Vaccine (Recombinant) Price (US$/Unit), 2016-2027
Figure 12. By Application - Global Hepatitis B Vaccine (Recombinant) Sales Market Share, 2016-2027
Figure 13. By Application - Global Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2016-2027
Figure 14. By Application - Global Hepatitis B Vaccine (Recombinant) Price (US$/Unit), 2016-2027
Figure 15. By Region - Global Hepatitis B Vaccine (Recombinant) Sales Market Share, 2016-2027
Figure 16. By Region - Global Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2016-2027
Figure 17. By Country - North America Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2016-2027
Figure 18. By Country - North America Hepatitis B Vaccine (Recombinant) Sales Market Share, 2016-2027
Figure 19. US Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Hepatitis B Vaccine (Recombinant) Sales Market Share, 2016-2027
Figure 24. Germany Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 25. France Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Hepatitis B Vaccine (Recombinant) Sales Market Share, 2016-2027
Figure 33. China Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 37. India Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2016-2027
Figure 39. By Country - South America Hepatitis B Vaccine (Recombinant) Sales Market Share, 2016-2027
Figure 40. Brazil Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share, 2016-2027
Figure 44. Turkey Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2016-2027
Figure 48. Global Hepatitis B Vaccine (Recombinant) Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Hepatitis B Vaccine (Recombinant) by Region, 2020 VS 2027
Figure 50. Hepatitis B Vaccine (Recombinant) Industry Value Chain
Figure 51. Marketing Channels


More Publications